Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Wolf H. Fridman

Wolf H. Fridman publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

ORCID 0000-0002-1332-0973 OpenAlex
World rank
#66,739
of 7,710,434 ranked researchers
Rank in France
#6,345
of 324,115
Works
1,042
Citations
91k
Citations per work
87.3
h-index
120
i10-index 455Top 0.2% in Immunology
Wolf H. Fridman

What does Wolf H. Fridman research?

Wolf H. Fridman's work is mostly in Immunology and Microbiology (34%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (13%).

Life Sciences: 490 works · 47.0% of their workImmunology and Microbiology: 351 works · 33.7% of their workImmunology: 351 works · 33.7% of their workBiochemistry, Genetics and Molecular Biology: 139 works · 13.3% of their workMolecular Biology: 139 works · 13.3% of their workHealth Sciences: 346 works · 33.2% of their workMedicine: 346 works · 33.2% of their workOncology: 169 works · 16.2% of their workRadiology, Nuclear Medicine and Imaging: 105 works · 10.1% of their workPulmonary and Respiratory Medicine: 40 works · 3.8% of their workHematology: 32 works · 3.1% of their workEverything else: 206 works · 19.8% of their workTHEIR WORKWolf H. Fridman1,042works
Life Sciences47%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology35133.7%
    2. Biochemistry, Genetics and Molecular Biology13913.3%
    1. Medicine34633.2%
  3. Everything else20619.8%
  1. 1Immunology34% of their works
  2. 2Oncology16% of their works
  3. 3Molecular Biology13% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Hematology3% of their works

Research topics

Which keywords describe Wolf H. Fridman's research?

The keywords of their largest research topics: Glycosylation, Cancer Immunotherapy, Immunity, Fc Receptors, Therapeutic Antibodies, Immune Checkpoint Blockade, PD-1 and PD-L1 and Antigen Presentation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Glycosylation3132 topics
  2. Cancer Immunotherapy2362 topics
  3. Immunity2362 topics
  4. Fc Receptors2011 topic
  5. Therapeutic Antibodies2011 topic
  6. Immune Checkpoint Blockade2001 topic
  7. PD-1 and PD-L12001 topic
  8. Antigen Presentation1901 topic
  9. Dendritic Cells1901 topic
  10. NK Cell Recognition1621 topic
  11. Natural Killer Cells1621 topic
  12. Cancer1582 topics
  13. Foxp31341 topic
  14. TGF-ß1341 topic
  15. Glycans1121 topic
  16. Immune System1121 topic
  17. Activation461 topic
  18. CAR T Cells461 topic
  19. Chimeric Antigen Receptor461 topic
  20. Macrophage461 topic

Where does Wolf H. Fridman work?

Wolf H. Fridman's main affiliation in the publication record is Inserm, France.

How many publications and citations does Wolf H. Fridman have?

OpenAlex counts 1,042 works and 91,003 citations for Wolf H. Fridman, an h-index of 120, ranking #66,739 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wolf H. Fridman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.